Navigation Links
Woolly-mammoth gene study changes extinction theory
Date:6/11/2008

y, Russia, Spain, Sweden, the United Kingdom, and the United States. The team includes experts in the fields of genome evolution, ancient DNA, and mammoth paleontology, as well as curators from various natural-history museums.

Another important finding for understanding the extinction processes is that the individuals in each of the two woolly-mammoth groups were related very closely to one another. "This low genetic divergence is surprising because the woolly mammoth had an extraordinarily wide range: from Western Europe, to the Bering Strait in Siberia, to Northern America," Miller said. "The low genetic divergence of mammoth, which we discovered, may have degraded the biological fitness of these animals in a time of changing environments and other challenges."

Our study suggests a genetic divergence of the two woolly-mammoth groups more than 1-million years ago, which is one quarter the genetic distance that separates Indian and African elephants and woolly mammoths," Miller said. The research indicates that the diversity of the two woolly-mammoth populations was as low centuries ago as it is now in the very small populations of Asian elephants living in southern India. "The low genetic divergence of the elephants in southern Indian has been suggested as contributing to the problems of maintaining this group as a thriving population," Schuster said. Intriguingly, the mitochondrial genomes revealed by the researchers are several times more complete than those known for the modern Indian and African Elephants combined.

Whereas studies before this research had analyzed only short segments of the DNA of extinct species, this new study generated and compared 18 complete genomes of the extinct woolly mammoth using mitochondrial DNA, an important material for studying ancient genes. This achievement is based on an earlier discovery of the team led by Miller, Schuster, and co-author Thomas Gilbert, which was published last ye
'/>"/>

Contact: Barbara K. Kennedy
science@psu.edu
814-863-4682
Penn State
Source:Eurekalert  

Page: 1 2 3 4

Related biology news :

1. From Canada to the Caribbean: Tree leaves control their own temperature, Penn study reveals
2. Study of guanacos launched in Chile
3. New study reveals large scale conservation essential
4. Study finds Chinese food good for your heart
5. Study identifies brain pathway that shuts down seizures
6. NOAA study shows eastern tropical pacific ocean dolphin populations improving
7. RAND study finds increase in piracy and terrorism at sea
8. Moores UCSD Cancer Center study links vitamin D, type 1 diabetes
9. UNH receives $380,000 grant to study organic dairy as closed ecosystem
10. Study finds healthy intestinal bacteria within chicken eggs
11. Study findings show infection control intervention helps keep kids in school
Post Your Comments:
*Name:
*Comment:
*Email:
Related Image:
Woolly-mammoth gene study changes extinction theory
Woolly-mammoth gene study changes extinction theory
(Date:12/4/2009)By measuring the total gene activity in organs relevant for coronary artery disease (CAD), scientists at the Swedish medical university Karolinska Institutet have identified a module of genes that is
(Date:12/4/2009)Using a new mathematical model of heart cells, University of Iowa investigators have shown how activation of a critical enzyme, calmodulin kinase II (CaM kinase), disrupts the electrical activity of h
(Date:12/3/2009)Our ability to learn new information and adapt to changes in our daily environment, as well as to retain lifelong memories, appears to lie in the minute junctions where nerve cells communicate, accord
Breaking Biology News(10 mins):Scientists discover gene module underlying atherosclerosis development 2U-Iowa study helps advance heart-related research 2Lifelong memories linked to stable nerve connections 2 26quot 3BAprima Medical Software Inc 26quot 3B Unveiled by iMedica 3B Premier EHR PM Company Adopts New Name 51818 1 26quot 3BAprima Medical Software Inc 26quot 3B Unveiled by iMedica 3B Premier EHR PM Company Adopts New Name 51818 2 26quot 3BAprima Medical Software Inc 26quot 3B Unveiled by iMedica 3B Premier EHR PM Company Adopts New Name 51818 3Key Protein Might Shield Brain Cells 51813 1Hard To Treat Diseases 28HTDS PK 29 Tender Order To Indonesia 51808 1Hard To Treat Diseases 28HTDS PK 29 Tender Order To Indonesia 51808 2
...) The February edition of the Journal of Nutriti... between infant feeding and health outcomes relate....D., professor of clinical epidemiology at the Uni...vascular in the Department of Medicine at the Oreg...thors of the report, "A longer period of breastfee...
... a mathematical model of the mating game to help e...y, by researchers at UCL (University College Londo...f Economics and Political Science), shows that ext...bility to a female and enables the female to scree...he research, published this month in the Journal ...
...disease nephropathia epidemica (NE) has been linke...tter summers, milder winters and increased seedcro...d in BioMed Central,s open access International J...his rodent-borne disease to known effects of globa...f Microbiology & Immunology at Belgium,s Rega Inst...
Other Biology News:New infant feeding and obesity research adds insight to ongoing issue 2Why you can't hurry love 2Why you can't hurry love 3Global warming linked to European viral epidemic 2
(Date:12/2/2009)NEW YORK, Dec. 2 Reportlinker.com announces that a new market research report is available in its catalogue: ,, Drug Discovery Technologies - A Global Update of Market Trends & Opportunities ,,
(Date:12/2/2009)TUSTIN, Calif., Dec. 2 Peregrine Pharmaceuticals, Inc. (Nasdaq: PPHM ) today reported completion of patient enrollment in a dose confirmation and dosimetry trial of Cotara® in patients with rel
(Date:12/2/2009)LELYSTAD, The Netherlands, December 2 Pepscan Holding NV,the Netherlands based biotechnology company focusing on protein mimicking,technology for the generation of immune therapeutics today announced
(Date:12/2/2009)SINGAPORE, Dec. 2 S*BIO Pte Ltd today announced data presentations on its novel oral JAK2 inhibitor, SB1518, at The American Society of Hematology 51st Annual Meeting and Exposition in New Orleans. ,
Breaking Biology Technology:Reportlinker Adds Drug Discovery Technologies - A Global Update of Market Trends & Opportunities 2Reportlinker Adds Drug Discovery Technologies - A Global Update of Market Trends & Opportunities 3Reportlinker Adds Drug Discovery Technologies - A Global Update of Market Trends & Opportunities 4Reportlinker Adds Drug Discovery Technologies - A Global Update of Market Trends & Opportunities 5Reportlinker Adds Drug Discovery Technologies - A Global Update of Market Trends & Opportunities 6Reportlinker Adds Drug Discovery Technologies - A Global Update of Market Trends & Opportunities 7Reportlinker Adds Drug Discovery Technologies - A Global Update of Market Trends & Opportunities 8Reportlinker Adds Drug Discovery Technologies - A Global Update of Market Trends & Opportunities 9Peregrine Completes Patient Enrollment in Cotara(R) Dose Confirmation and Dosimetry Brain Cancer Trial 2Peregrine Completes Patient Enrollment in Cotara(R) Dose Confirmation and Dosimetry Brain Cancer Trial 3Peregrine Completes Patient Enrollment in Cotara(R) Dose Confirmation and Dosimetry Brain Cancer Trial 4Peregrine Completes Patient Enrollment in Cotara(R) Dose Confirmation and Dosimetry Brain Cancer Trial 5Dutch Biotech Company Pepscan Appoints New CEO 2S*BIO Novel Oral JAK2 Inhibitor SB1518 Demonstrates Safety and Tolerability in Phase 1 Studies for the Treatment of Myeloproliferative and Other Hematological Disorders 2S*BIO Novel Oral JAK2 Inhibitor SB1518 Demonstrates Safety and Tolerability in Phase 1 Studies for the Treatment of Myeloproliferative and Other Hematological Disorders 3S*BIO Novel Oral JAK2 Inhibitor SB1518 Demonstrates Safety and Tolerability in Phase 1 Studies for the Treatment of Myeloproliferative and Other Hematological Disorders 4S*BIO Novel Oral JAK2 Inhibitor SB1518 Demonstrates Safety and Tolerability in Phase 1 Studies for the Treatment of Myeloproliferative and Other Hematological Disorders 5
...2008 - Book signing to follow his presentation, W...environment, elements of the global marketplace, a...Tech Conference., Wednesday panel presentations w...ry with the wireless & IT sectors, remote patient ...er when entering M&A transactions,China,s health c...
...Florida researcher may have found a defense agains...rd of Europe,s population in the Middle Ages and w...hreat today. , UCF Professor Henry Daniell and h...ch shows is highly effective against the plague. F...SDA funded research appear in the August edition o...
..., 2008 -- A new interactive web lesson teaches upp...nts how herbicides are developed. The lesson, deve..., has the seal of approval by the Journal of Natu...published in the 2008 issue. , Surprisingly, almo...discovered by random searching. Collections of che...
Other Biology Technology:Former Speaker of the House Newt Gingrich Featured Wednesday 2UCF professor develops vaccine to protect against black plague bioterror attack 2UCF professor develops vaccine to protect against black plague bioterror attack 3
Goat Anti-Human Serpin B5 / Maspin Polyclonal Antibody, Unconjugated from R&D Systems
...29 cm, 1. One system for gel staining and blot pr...ilver-stain gels for proteins and nucleic acid ana...ection and chromogenic detection. Programmable con... time.Proven design for consistent, high-quality p...
...SDA Research Registered OLAW Assured AAALAC Accred...LAS Certified Technicians Documentation GLP Proc...est Focus CRP is your one stop shopping point fo...fer free project consultation, free peptide sequen...
..., FHS-LVF, and the CVD-Diffuse We've combined our...ilters to create the world's first notch filter wi...bandpass. Each filter features an excellent transm...se filters -- with interference coatings applied t...
Biology Products: